[Present-day infectious endocarditis (part II)].
Tazina
S Ia
SIa
Gurevich
M A
MA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000900:Anti-Bacterial Agents; D000925:Anticoagulants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004452:Echocardiography; D004562:Electrocardiography; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D013210:Staphylococcus / Q000302:isolation & purification; D013290:Streptococcal Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D013291:Streptococcus / Q000302:isolation & purification
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D005938:Glucocorticoids